Pharmacological trials: primary and secondary prevention of coronary heart disease.
D001241:Aspirin / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D003327:Coronary Disease / Q000517:prevention & control*; D003918:Dextrothyroxine / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000627:therapeutic use; D013442:Sulfinpyrazone / Q000627:therapeutic use
D004967:Estrogens; D002792:Cholestyramine Resin; D009525:Niacin; D003918:Dextrothyroxine; D004176:Dipyridamole; D002994:Clofibrate; D003084:Colestipol; D001241:Aspirin; D013442:Sulfinpyrazone